Biopharma stock Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, up 20.6% at $22.17 at last glance. The biopharmaceutical company announced a strategic restructuring plan, laying off about 500 ...

According to Benzinga Pro, Legend Biotech's peer group average for short interest as a percentage of float is 13.20%, which means the company has less short interest than most of its peers. Did you ...

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 10% after the clinical-stage biopharmaceutical company announced the publication of promising preclinical data from its ...

Sarepta's cost-saving moves, FDA surprises, and pipeline potential position SRPT as a unique opportunity. Read here for an ...

On May 6, Arcutis reported first-quarter results showed loss of 20 cents a share, which slightly beat estimates. Its sales ...

Sarepta Therapeutics, Inc. faces setbacks with Elevidys, safety issues, and workforce cuts, raising concerns about its ...

Alphabet (Google) is investing in biotech penny stocks. Should you? Explore Alphabet's investment strategy and discover potential penny stocks to consider.

On the first point, we talk a lot around here about small public companies that get gobbled up by crypto entrepreneurs so ...

Regulatory upheaval in the US and a venture capital drought are dampening investor appetites, but there are still diamonds in ...

The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...

Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall ...

Following closely was ARK’s investment in Tempus AI Inc (TEM), where the firm bought 158,051 shares across its ARKK and ARKG ETFs, totaling $8,833,470. This purchase continues a recent trend of ARK ...